About SCHOTT Poonawalla
SCHOTT Poonawalla is a company based in Mumbai (India) founded in 1990. The company has 1,372 employees as of March 21, 2024. SCHOTT Poonawalla offers products and services including Syringes, Cartridges, Vials, Ampoules, and Regulatory Services. SCHOTT Poonawalla operates in a competitive market with competitors including Ideal Cures, Sanner, Natural Capsules, Legacy Pharma Solutions and Eulysis, among others.
- Headquarter Mumbai, India
- Employees 1372 as on 21 Mar, 2024
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Schott Poonawalla Private Limited
- Date of Incorporation 21 Dec, 1994
- Jurisdiction Mumbai, Maharashtra, India
-
Annual Revenue
$115.59 M (USD)32.17as on Mar 31, 2022
-
Net Profit
$27.43 M (USD)105.44as on Mar 31, 2022
-
EBITDA
$42.95 M (USD)41.2as on Mar 31, 2022
-
Latest Funding Round
Not available
-
Investors
Serum Institute of India
& 1 more
-
Employee Count
1372
as on Mar 21, 2024
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of SCHOTT Poonawalla
SCHOTT Poonawalla offers a comprehensive portfolio of products and services, including Syringes, Cartridges, Vials, Ampoules, and Regulatory Services.
Prefillable glass syringes for vaccines and injectables
Glass cartridges for peptide and protein-based drugs
Glass vials for secure storage of injectables
Glass ampoules for drug protection against counterfeiting
Services for drug master files and certificates
Funding Insights of SCHOTT Poonawalla
Investors in SCHOTT Poonawalla
SCHOTT Poonawalla has secured backing from 2 investors, including institutional investors. Prominent investors backing the company include Serum Institute of India and TPG Scion Unit Trust.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Vaccines and immuno-biological drugs for infectious diseases are manufactured.
|
Locked | Locked | Locked | |
|
-
|
Locked | Locked | Locked |
Investor details for SCHOTT Poonawalla
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by SCHOTT Poonawalla
Investment portfolio details for SCHOTT Poonawalla
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - SCHOTT Poonawalla
Detailed financials for SCHOTT Poonawalla
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Schott Poonawalla Comparisons
Peer comparison for SCHOTT Poonawalla
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of SCHOTT Poonawalla
SCHOTT Poonawalla operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Ideal Cures, Sanner, Natural Capsules, Legacy Pharma Solutions and Eulysis, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Manufacturer of pharmaceutical excipients and coatings systems for solid oral dosage forms
|
|
| Locked | Locked | Locked |
Plastic packaging solutions for pharmaceutical products are manufactured.
|
|
| Locked | Locked | Locked |
Manufacturing and supply chain services for biopharma sector are provided.
|
|
| Locked | Locked | Locked |
Contract pharmaceutical packaging company
|
|
| Locked | Locked | Locked |
Diabetes management and lifestyle modification services are provided.
|
Detailed competitors of SCHOTT Poonawalla
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Schott Poonawalla
Complete news archive for SCHOTT Poonawalla
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about SCHOTT Poonawalla
SCHOTT Poonawalla was founded in 1990 and raised its 1st funding round 31 years after it was founded.
SCHOTT Poonawalla is headquartered in Mumbai, India. It is registered at Mumbai, Maharashtra, India.
As of Mar 21, 2024, the latest employee count at SCHOTT Poonawalla is 1,372.
Annual revenue of SCHOTT Poonawalla is $115.59M as on Mar 31, 2022.
SCHOTT Poonawalla was established in 1990 in Mumbai, India, as a provider of packaging solutions for the pharmaceutical and biotech sectors. Primary packaging options such as cartridges, glass vials, ampoules, and prefillable syringes are included in its portfolio. Services encompassing drug development, research, analytical testing, and regulatory support are extended to pharmaceutical and biotech firms operating in these industries.
SCHOTT Poonawalla's top competitors include Legacy Pharma Solutions, Natural Capsules and Ideal Cures.
SCHOTT Poonawalla offers Syringes, Cartridges, Vials, Ampoules, and Regulatory Services.
SCHOTT Poonawalla has 2 investors. Key investors include Serum Institute of India, and TPG Scion Unit Trust.